Medical Care
Global Alzheimer's Disease Diagnostic Market Research Report 2024
- Jan 20, 24
- ID: 19681
- Pages: 71
- Figures: 143
- Views: 43
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
The global Alzheimer's Disease Diagnostic market was valued at US$ 3618 million in 2023 and is anticipated to reach US$ 4024.3 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Diagnostic.
Report Scope
The Alzheimer's Disease Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alzheimer's Disease Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer's Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
TauRx
Alector
Accera
Treventis
Neuro-Bio
Cognition Therapeutics
Segment by Type
Genetic Testing
Neurological Exam
Mini-Mental State Exam(MMSE)
Brain Imaging
Other
Segment by Application
Clinics
Hospitals
Diagnostic Centers
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer's Disease Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Alzheimer's Disease Diagnostic market was valued at US$ 3618 million in 2023 and is anticipated to reach US$ 4024.3 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Diagnostic.
Report Scope
The Alzheimer's Disease Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alzheimer's Disease Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer's Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
TauRx
Alector
Accera
Treventis
Neuro-Bio
Cognition Therapeutics
Segment by Type
Genetic Testing
Neurological Exam
Mini-Mental State Exam(MMSE)
Brain Imaging
Other
Segment by Application
Clinics
Hospitals
Diagnostic Centers
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer's Disease Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Genetic Testing
1.2.3 Neurological Exam
1.2.4 Mini-Mental State Exam(MMSE)
1.2.5 Brain Imaging
1.2.6 Other
1.3 Market by Application
1.3.1 Global Alzheimer's Disease Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Diagnostic Centers
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer's Disease Diagnostic Market Perspective (2019-2030)
2.2 Alzheimer's Disease Diagnostic Growth Trends by Region
2.2.1 Global Alzheimer's Disease Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Alzheimer's Disease Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Alzheimer's Disease Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Alzheimer's Disease Diagnostic Market Dynamics
2.3.1 Alzheimer's Disease Diagnostic Industry Trends
2.3.2 Alzheimer's Disease Diagnostic Market Drivers
2.3.3 Alzheimer's Disease Diagnostic Market Challenges
2.3.4 Alzheimer's Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer's Disease Diagnostic Players by Revenue
3.1.1 Global Top Alzheimer's Disease Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Alzheimer's Disease Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Alzheimer's Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alzheimer's Disease Diagnostic Revenue
3.4 Global Alzheimer's Disease Diagnostic Market Concentration Ratio
3.4.1 Global Alzheimer's Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Diagnostic Revenue in 2023
3.5 Alzheimer's Disease Diagnostic Key Players Head office and Area Served
3.6 Key Players Alzheimer's Disease Diagnostic Product Solution and Service
3.7 Date of Enter into Alzheimer's Disease Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer's Disease Diagnostic Breakdown Data by Type
4.1 Global Alzheimer's Disease Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Type (2025-2030)
5 Alzheimer's Disease Diagnostic Breakdown Data by Application
5.1 Global Alzheimer's Disease Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Alzheimer's Disease Diagnostic Market Size (2019-2030)
6.2 North America Alzheimer's Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Alzheimer's Disease Diagnostic Market Size by Country (2019-2024)
6.4 North America Alzheimer's Disease Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer's Disease Diagnostic Market Size (2019-2030)
7.2 Europe Alzheimer's Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Alzheimer's Disease Diagnostic Market Size by Country (2019-2024)
7.4 Europe Alzheimer's Disease Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer's Disease Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Alzheimer's Disease Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer's Disease Diagnostic Market Size (2019-2030)
9.2 Latin America Alzheimer's Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Alzheimer's Disease Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Alzheimer's Disease Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer's Disease Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Alzheimer's Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Alzheimer's Disease Diagnostic Introduction
11.1.4 Eli Lilly Revenue in Alzheimer's Disease Diagnostic Business (2019-2024)
11.1.5 Eli Lilly Recent Development
11.2 TauRx
11.2.1 TauRx Company Detail
11.2.2 TauRx Business Overview
11.2.3 TauRx Alzheimer's Disease Diagnostic Introduction
11.2.4 TauRx Revenue in Alzheimer's Disease Diagnostic Business (2019-2024)
11.2.5 TauRx Recent Development
11.3 Alector
11.3.1 Alector Company Detail
11.3.2 Alector Business Overview
11.3.3 Alector Alzheimer's Disease Diagnostic Introduction
11.3.4 Alector Revenue in Alzheimer's Disease Diagnostic Business (2019-2024)
11.3.5 Alector Recent Development
11.4 Accera
11.4.1 Accera Company Detail
11.4.2 Accera Business Overview
11.4.3 Accera Alzheimer's Disease Diagnostic Introduction
11.4.4 Accera Revenue in Alzheimer's Disease Diagnostic Business (2019-2024)
11.4.5 Accera Recent Development
11.5 Treventis
11.5.1 Treventis Company Detail
11.5.2 Treventis Business Overview
11.5.3 Treventis Alzheimer's Disease Diagnostic Introduction
11.5.4 Treventis Revenue in Alzheimer's Disease Diagnostic Business (2019-2024)
11.5.5 Treventis Recent Development
11.6 Neuro-Bio
11.6.1 Neuro-Bio Company Detail
11.6.2 Neuro-Bio Business Overview
11.6.3 Neuro-Bio Alzheimer's Disease Diagnostic Introduction
11.6.4 Neuro-Bio Revenue in Alzheimer's Disease Diagnostic Business (2019-2024)
11.6.5 Neuro-Bio Recent Development
11.7 Cognition Therapeutics
11.7.1 Cognition Therapeutics Company Detail
11.7.2 Cognition Therapeutics Business Overview
11.7.3 Cognition Therapeutics Alzheimer's Disease Diagnostic Introduction
11.7.4 Cognition Therapeutics Revenue in Alzheimer's Disease Diagnostic Business (2019-2024)
11.7.5 Cognition Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Genetic Testing
1.2.3 Neurological Exam
1.2.4 Mini-Mental State Exam(MMSE)
1.2.5 Brain Imaging
1.2.6 Other
1.3 Market by Application
1.3.1 Global Alzheimer's Disease Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Diagnostic Centers
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer's Disease Diagnostic Market Perspective (2019-2030)
2.2 Alzheimer's Disease Diagnostic Growth Trends by Region
2.2.1 Global Alzheimer's Disease Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Alzheimer's Disease Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Alzheimer's Disease Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Alzheimer's Disease Diagnostic Market Dynamics
2.3.1 Alzheimer's Disease Diagnostic Industry Trends
2.3.2 Alzheimer's Disease Diagnostic Market Drivers
2.3.3 Alzheimer's Disease Diagnostic Market Challenges
2.3.4 Alzheimer's Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer's Disease Diagnostic Players by Revenue
3.1.1 Global Top Alzheimer's Disease Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Alzheimer's Disease Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Alzheimer's Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alzheimer's Disease Diagnostic Revenue
3.4 Global Alzheimer's Disease Diagnostic Market Concentration Ratio
3.4.1 Global Alzheimer's Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Diagnostic Revenue in 2023
3.5 Alzheimer's Disease Diagnostic Key Players Head office and Area Served
3.6 Key Players Alzheimer's Disease Diagnostic Product Solution and Service
3.7 Date of Enter into Alzheimer's Disease Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer's Disease Diagnostic Breakdown Data by Type
4.1 Global Alzheimer's Disease Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Type (2025-2030)
5 Alzheimer's Disease Diagnostic Breakdown Data by Application
5.1 Global Alzheimer's Disease Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Alzheimer's Disease Diagnostic Market Size (2019-2030)
6.2 North America Alzheimer's Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Alzheimer's Disease Diagnostic Market Size by Country (2019-2024)
6.4 North America Alzheimer's Disease Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer's Disease Diagnostic Market Size (2019-2030)
7.2 Europe Alzheimer's Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Alzheimer's Disease Diagnostic Market Size by Country (2019-2024)
7.4 Europe Alzheimer's Disease Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer's Disease Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Alzheimer's Disease Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer's Disease Diagnostic Market Size (2019-2030)
9.2 Latin America Alzheimer's Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Alzheimer's Disease Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Alzheimer's Disease Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer's Disease Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Alzheimer's Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Alzheimer's Disease Diagnostic Introduction
11.1.4 Eli Lilly Revenue in Alzheimer's Disease Diagnostic Business (2019-2024)
11.1.5 Eli Lilly Recent Development
11.2 TauRx
11.2.1 TauRx Company Detail
11.2.2 TauRx Business Overview
11.2.3 TauRx Alzheimer's Disease Diagnostic Introduction
11.2.4 TauRx Revenue in Alzheimer's Disease Diagnostic Business (2019-2024)
11.2.5 TauRx Recent Development
11.3 Alector
11.3.1 Alector Company Detail
11.3.2 Alector Business Overview
11.3.3 Alector Alzheimer's Disease Diagnostic Introduction
11.3.4 Alector Revenue in Alzheimer's Disease Diagnostic Business (2019-2024)
11.3.5 Alector Recent Development
11.4 Accera
11.4.1 Accera Company Detail
11.4.2 Accera Business Overview
11.4.3 Accera Alzheimer's Disease Diagnostic Introduction
11.4.4 Accera Revenue in Alzheimer's Disease Diagnostic Business (2019-2024)
11.4.5 Accera Recent Development
11.5 Treventis
11.5.1 Treventis Company Detail
11.5.2 Treventis Business Overview
11.5.3 Treventis Alzheimer's Disease Diagnostic Introduction
11.5.4 Treventis Revenue in Alzheimer's Disease Diagnostic Business (2019-2024)
11.5.5 Treventis Recent Development
11.6 Neuro-Bio
11.6.1 Neuro-Bio Company Detail
11.6.2 Neuro-Bio Business Overview
11.6.3 Neuro-Bio Alzheimer's Disease Diagnostic Introduction
11.6.4 Neuro-Bio Revenue in Alzheimer's Disease Diagnostic Business (2019-2024)
11.6.5 Neuro-Bio Recent Development
11.7 Cognition Therapeutics
11.7.1 Cognition Therapeutics Company Detail
11.7.2 Cognition Therapeutics Business Overview
11.7.3 Cognition Therapeutics Alzheimer's Disease Diagnostic Introduction
11.7.4 Cognition Therapeutics Revenue in Alzheimer's Disease Diagnostic Business (2019-2024)
11.7.5 Cognition Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Genetic Testing
Table 3. Key Players of Neurological Exam
Table 4. Key Players of Mini-Mental State Exam(MMSE)
Table 5. Key Players of Brain Imaging
Table 6. Key Players of Other
Table 7. Global Alzheimer's Disease Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Alzheimer's Disease Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Alzheimer's Disease Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Alzheimer's Disease Diagnostic Market Share by Region (2019-2024)
Table 11. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Alzheimer's Disease Diagnostic Market Share by Region (2025-2030)
Table 13. Alzheimer's Disease Diagnostic Market Trends
Table 14. Alzheimer's Disease Diagnostic Market Drivers
Table 15. Alzheimer's Disease Diagnostic Market Challenges
Table 16. Alzheimer's Disease Diagnostic Market Restraints
Table 17. Global Alzheimer's Disease Diagnostic Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Alzheimer's Disease Diagnostic Market Share by Players (2019-2024)
Table 19. Global Top Alzheimer's Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnostic as of 2023)
Table 20. Ranking of Global Top Alzheimer's Disease Diagnostic Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Alzheimer's Disease Diagnostic Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Alzheimer's Disease Diagnostic Product Solution and Service
Table 24. Date of Enter into Alzheimer's Disease Diagnostic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Alzheimer's Disease Diagnostic Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Alzheimer's Disease Diagnostic Revenue Market Share by Type (2019-2024)
Table 28. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Alzheimer's Disease Diagnostic Revenue Market Share by Type (2025-2030)
Table 30. Global Alzheimer's Disease Diagnostic Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Alzheimer's Disease Diagnostic Revenue Market Share by Application (2019-2024)
Table 32. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Alzheimer's Disease Diagnostic Revenue Market Share by Application (2025-2030)
Table 34. North America Alzheimer's Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Alzheimer's Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Alzheimer's Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Alzheimer's Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Alzheimer's Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Alzheimer's Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Alzheimer's Disease Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Alzheimer's Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Alzheimer's Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Alzheimer's Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Alzheimer's Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 49. Eli Lilly Company Detail
Table 50. Eli Lilly Business Overview
Table 51. Eli Lilly Alzheimer's Disease Diagnostic Product
Table 52. Eli Lilly Revenue in Alzheimer's Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 53. Eli Lilly Recent Development
Table 54. TauRx Company Detail
Table 55. TauRx Business Overview
Table 56. TauRx Alzheimer's Disease Diagnostic Product
Table 57. TauRx Revenue in Alzheimer's Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 58. TauRx Recent Development
Table 59. Alector Company Detail
Table 60. Alector Business Overview
Table 61. Alector Alzheimer's Disease Diagnostic Product
Table 62. Alector Revenue in Alzheimer's Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 63. Alector Recent Development
Table 64. Accera Company Detail
Table 65. Accera Business Overview
Table 66. Accera Alzheimer's Disease Diagnostic Product
Table 67. Accera Revenue in Alzheimer's Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 68. Accera Recent Development
Table 69. Treventis Company Detail
Table 70. Treventis Business Overview
Table 71. Treventis Alzheimer's Disease Diagnostic Product
Table 72. Treventis Revenue in Alzheimer's Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 73. Treventis Recent Development
Table 74. Neuro-Bio Company Detail
Table 75. Neuro-Bio Business Overview
Table 76. Neuro-Bio Alzheimer's Disease Diagnostic Product
Table 77. Neuro-Bio Revenue in Alzheimer's Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 78. Neuro-Bio Recent Development
Table 79. Cognition Therapeutics Company Detail
Table 80. Cognition Therapeutics Business Overview
Table 81. Cognition Therapeutics Alzheimer's Disease Diagnostic Product
Table 82. Cognition Therapeutics Revenue in Alzheimer's Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 83. Cognition Therapeutics Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer's Disease Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Alzheimer's Disease Diagnostic Market Share by Type: 2023 VS 2030
Figure 3. Genetic Testing Features
Figure 4. Neurological Exam Features
Figure 5. Mini-Mental State Exam(MMSE) Features
Figure 6. Brain Imaging Features
Figure 7. Other Features
Figure 8. Global Alzheimer's Disease Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Alzheimer's Disease Diagnostic Market Share by Application: 2023 VS 2030
Figure 10. Clinics Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Diagnostic Centers Case Studies
Figure 13. Other Case Studies
Figure 14. Alzheimer's Disease Diagnostic Report Years Considered
Figure 15. Global Alzheimer's Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Alzheimer's Disease Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Alzheimer's Disease Diagnostic Market Share by Region: 2023 VS 2030
Figure 18. Global Alzheimer's Disease Diagnostic Market Share by Players in 2023
Figure 19. Global Top Alzheimer's Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnostic as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Alzheimer's Disease Diagnostic Revenue in 2023
Figure 21. North America Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Alzheimer's Disease Diagnostic Market Share by Country (2019-2030)
Figure 23. United States Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Alzheimer's Disease Diagnostic Market Share by Country (2019-2030)
Figure 27. Germany Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Alzheimer's Disease Diagnostic Market Share by Region (2019-2030)
Figure 35. China Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Alzheimer's Disease Diagnostic Market Share by Country (2019-2030)
Figure 43. Mexico Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Alzheimer's Disease Diagnostic Market Share by Country (2019-2030)
Figure 47. Turkey Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Eli Lilly Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2019-2024)
Figure 50. TauRx Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2019-2024)
Figure 51. Alector Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2019-2024)
Figure 52. Accera Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2019-2024)
Figure 53. Treventis Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2019-2024)
Figure 54. Neuro-Bio Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2019-2024)
Figure 55. Cognition Therapeutics Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Genetic Testing
Table 3. Key Players of Neurological Exam
Table 4. Key Players of Mini-Mental State Exam(MMSE)
Table 5. Key Players of Brain Imaging
Table 6. Key Players of Other
Table 7. Global Alzheimer's Disease Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Alzheimer's Disease Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Alzheimer's Disease Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Alzheimer's Disease Diagnostic Market Share by Region (2019-2024)
Table 11. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Alzheimer's Disease Diagnostic Market Share by Region (2025-2030)
Table 13. Alzheimer's Disease Diagnostic Market Trends
Table 14. Alzheimer's Disease Diagnostic Market Drivers
Table 15. Alzheimer's Disease Diagnostic Market Challenges
Table 16. Alzheimer's Disease Diagnostic Market Restraints
Table 17. Global Alzheimer's Disease Diagnostic Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Alzheimer's Disease Diagnostic Market Share by Players (2019-2024)
Table 19. Global Top Alzheimer's Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnostic as of 2023)
Table 20. Ranking of Global Top Alzheimer's Disease Diagnostic Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Alzheimer's Disease Diagnostic Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Alzheimer's Disease Diagnostic Product Solution and Service
Table 24. Date of Enter into Alzheimer's Disease Diagnostic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Alzheimer's Disease Diagnostic Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Alzheimer's Disease Diagnostic Revenue Market Share by Type (2019-2024)
Table 28. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Alzheimer's Disease Diagnostic Revenue Market Share by Type (2025-2030)
Table 30. Global Alzheimer's Disease Diagnostic Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Alzheimer's Disease Diagnostic Revenue Market Share by Application (2019-2024)
Table 32. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Alzheimer's Disease Diagnostic Revenue Market Share by Application (2025-2030)
Table 34. North America Alzheimer's Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Alzheimer's Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Alzheimer's Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Alzheimer's Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Alzheimer's Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Alzheimer's Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Alzheimer's Disease Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Alzheimer's Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Alzheimer's Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Alzheimer's Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Alzheimer's Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 49. Eli Lilly Company Detail
Table 50. Eli Lilly Business Overview
Table 51. Eli Lilly Alzheimer's Disease Diagnostic Product
Table 52. Eli Lilly Revenue in Alzheimer's Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 53. Eli Lilly Recent Development
Table 54. TauRx Company Detail
Table 55. TauRx Business Overview
Table 56. TauRx Alzheimer's Disease Diagnostic Product
Table 57. TauRx Revenue in Alzheimer's Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 58. TauRx Recent Development
Table 59. Alector Company Detail
Table 60. Alector Business Overview
Table 61. Alector Alzheimer's Disease Diagnostic Product
Table 62. Alector Revenue in Alzheimer's Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 63. Alector Recent Development
Table 64. Accera Company Detail
Table 65. Accera Business Overview
Table 66. Accera Alzheimer's Disease Diagnostic Product
Table 67. Accera Revenue in Alzheimer's Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 68. Accera Recent Development
Table 69. Treventis Company Detail
Table 70. Treventis Business Overview
Table 71. Treventis Alzheimer's Disease Diagnostic Product
Table 72. Treventis Revenue in Alzheimer's Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 73. Treventis Recent Development
Table 74. Neuro-Bio Company Detail
Table 75. Neuro-Bio Business Overview
Table 76. Neuro-Bio Alzheimer's Disease Diagnostic Product
Table 77. Neuro-Bio Revenue in Alzheimer's Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 78. Neuro-Bio Recent Development
Table 79. Cognition Therapeutics Company Detail
Table 80. Cognition Therapeutics Business Overview
Table 81. Cognition Therapeutics Alzheimer's Disease Diagnostic Product
Table 82. Cognition Therapeutics Revenue in Alzheimer's Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 83. Cognition Therapeutics Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer's Disease Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Alzheimer's Disease Diagnostic Market Share by Type: 2023 VS 2030
Figure 3. Genetic Testing Features
Figure 4. Neurological Exam Features
Figure 5. Mini-Mental State Exam(MMSE) Features
Figure 6. Brain Imaging Features
Figure 7. Other Features
Figure 8. Global Alzheimer's Disease Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Alzheimer's Disease Diagnostic Market Share by Application: 2023 VS 2030
Figure 10. Clinics Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Diagnostic Centers Case Studies
Figure 13. Other Case Studies
Figure 14. Alzheimer's Disease Diagnostic Report Years Considered
Figure 15. Global Alzheimer's Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Alzheimer's Disease Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Alzheimer's Disease Diagnostic Market Share by Region: 2023 VS 2030
Figure 18. Global Alzheimer's Disease Diagnostic Market Share by Players in 2023
Figure 19. Global Top Alzheimer's Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnostic as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Alzheimer's Disease Diagnostic Revenue in 2023
Figure 21. North America Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Alzheimer's Disease Diagnostic Market Share by Country (2019-2030)
Figure 23. United States Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Alzheimer's Disease Diagnostic Market Share by Country (2019-2030)
Figure 27. Germany Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Alzheimer's Disease Diagnostic Market Share by Region (2019-2030)
Figure 35. China Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Alzheimer's Disease Diagnostic Market Share by Country (2019-2030)
Figure 43. Mexico Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Alzheimer's Disease Diagnostic Market Share by Country (2019-2030)
Figure 47. Turkey Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Alzheimer's Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Eli Lilly Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2019-2024)
Figure 50. TauRx Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2019-2024)
Figure 51. Alector Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2019-2024)
Figure 52. Accera Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2019-2024)
Figure 53. Treventis Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2019-2024)
Figure 54. Neuro-Bio Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2019-2024)
Figure 55. Cognition Therapeutics Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Paint Leveling Agent Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Adhesion Promoters Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Rheological Additives Market Insights, Forecast to 2030
Dec 22, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232